GRI Bio
6 hedge funds and large institutions have $64.7K invested in GRI Bio in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
339% more capital invested
Capital invested by funds: $14.7K → $64.7K (+$49.9K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
1.89% more ownership
Funds ownership: 0.07% → 1.95% (+1.9%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
14% less funds holding
Funds holding: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$65.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$32.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.57K |
| 4 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
-$4.01K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5 |
| 3 |
BlackRock
New York
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $42.2K | +$65.6K | +17,610 | +2,127% |
|
|
2
UBS Group
Zurich,
Switzerland
| $20K | +$32.5K | +8,722 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2.43K | +$3.57K | +958 | +939% |
|
|
4
BlackRock
New York
| $16 | -$4 | -1 | -13% |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $9 | – | – | – |
|
|
DB
6
Danske Bank
Copenhagen K,
Denmark
| $5 | +$7 | +2 | New |
|
|
SG
7
StoneX Group
New York
| – | -$4.01K | -580 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$5 | -1 | Closed |
|
GRI Hedge Fund Activity: Q1 2026 in Review
6 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in GRI Bio (GRI) for Q1 2026, worth a combined $64.7K — up 339% from $14.7K a quarter earlier.
Fund positioning in GRI was balanced in Q1 2026: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $65.6K. The largest seller was StoneX Group, exiting entirely with an estimated $4.01K sold.
- 6 institutional investors held GRI Bio (GRI) as of Q1 2026, down from 7 in Q4 2025.
- Funds reported $64.7K of GRI Bio stock for Q1 2026, up 339% quarter-over-quarter.
- 2 funds opened new GRI Bio positions in Q1 2026 and 2 closed out, a net change of 0 holders.
- The largest GRI Bio buyer in Q1 2026 was Geode Capital Management, an estimated $65.6K added.
- The largest GRI Bio seller in Q1 2026 was StoneX Group, an estimated $4.01K sold.
Based on aggregated 13F filings for Q1 2026.